Skip to Main Content

Session by Topic Area

All

1. Keynote Address +Details
2. Keynote Address: Digital Health Technology—Raising Hopes or Raising Barriers? +Details
3. Year in Review +Details

Antitrust

13. Partnership Strategies: The Prizes and Pitfalls of Mergers, Joint Ventures, and Flying Solo +Details
21. Analyzing and Assessing the Impact of Contracts, Business Practices, and Mergers in Health Care on Labor Markets +Details
30. Antitrust and Competition Issues in the Pharma Industry +Details

Behavioral Health

15. Road to 988 Implementation: Rethinking our Crisis System +Details
23. Telebehavioral Health 2.0: Where We Are and Where We Are Going +Details
33. Silent Epidemic:  Workplace Violence in Behavioral Health and Acute Care Settings +Details

Business Law and Governance

7. Contracting Beyond Traditional Health Care Settings: Model for Virtual First Care (V1C) Payer/Provider Contracts +Details
20. Show me the Money: How to Advise Physician Practices When Private Equity comes Knocking on Their Door +Details
28. The End of Global and Professional Direct Contracting and Transition to ACO REACH: Redefining Physician Practice to Deliver Value +Details
32. What your Compliance Officer Is–and Isn't: Problems with the Dual Role of General Counsel and Chief Compliance Officer +Details
39. Achieving Your Organization’s Goals and Mission through Strategic Clinical and Corporate Governance +Details

Compliance

24. Now What? The New Normal in Health Care Vaccine Policies +Details
29. The Public Health Emergency (PHE) is Ending:  What Should Providers Expect Next? +Details
32. What your Compliance Officer Is–and Isn't: Problems with the Dual Role of General Counsel and Chief Compliance Officer +Details

Dispute Resolution

37. Annual Alternative Dispute Resolution Update +Details

Inclusion, Diversity, Equity, and Accessibility (IDEA)

19. Care and Support of Transgender Patients: Emerging Trends and Concerns, and How You Can Help +Details
35. DEI or DIE: Case Studies in What We’ve Learned About the DEI Imperative in the Post-COVID Transition +Details

Fraud and Abuse

14. DOJ Litigation and OIG Priorities +Details
16. The Digital Health Revolution is Here: Key Considerations for Addressing Fraud and Abuse Risk Areas and Compliance +Details
40. Home Health and Hospice in the Hot Seat-The Compliance Landscape in 2022 +Details

Health Care Liability and Litigation

14. DOJ Litigation and OIG Priorities +Details
36. Trends in ERISA Preemption: PBMs, State Consumer Fraud Laws, and State Regulation of Health Care +Details

Health Information Technology

9. Navigating the Information Blocking Fog: Practical Steps to Move from Confusion to Clarity +Details
16. The Digital Health Revolution is Here: Key Considerations for Addressing Fraud and Abuse Risk Areas and Compliance +Details
17. Telemedicine Post-COVID: Where Are We and What's Next? +Details
23. Telebehavioral Health 2.0: Where We Are and Where We Are Going +Details
27. Everything You Wanted to Know about Ransomware (but were Afraid to Ask) +Details

Hospitals and Health Systems

4. The Jetsons: Coming to a Hospital Near You! +Details
10. Hospital Charges under the Microscope: Operational Implications of the Price Transparency Rule and No Surprises Act +Details
41. When Disaster Strikes Again:  How to Prepare your Organization +Details

 

Labor and Employment

8. Recent Developments in Employment Law for the Health Law Professional +Details
11. Crossing I’s and Dotting T’s:  You Need To Pay Attention To The Details When Taking Action Against A Physician +Details
21. Analyzing and Assessing the Impact of Contracts, Business Practices, and Mergers in Health Care on Labor Markets +Details
24. Now What? The New Normal in Health Care Vaccine Policies +Details
25. The New General Counsel’s Agenda–Déjà Vu All Over Again +Details
33. Silent Epidemic:  Workplace Violence in Behavioral Health and Acute Care Settings +Details

Legal Ethics

6. Legal Ethics Like a Boss: What Bruce Springsteen Can Teach Health Care Lawyers About Professional Responsibility +Details
26. Ethical Challenges and the Impact of “Artificial Intelligence” on the Practice of Law and Medicine +Details

Life Sciences

26. Ethical Challenges and the Impact of “Artificial Intelligence” on the Practice of Law and Medicine +Details
30. Antitrust and Competition Issues in the Pharma Industry +Details

Long Term Care

5. Liability in Long Term Care +Details
40. Home Health and Hospice in the Hot Seat-The Compliance Landscape in 2022 +Details

Medical Staff, Credentialing, and Peer Review

11. Crossing I’s and Dotting T’s:  You Need To Pay Attention To The Details When Taking Action Against A Physician +Details

Payers, Plans, and Managed Care

18. Risk Adjustment and False Claims Act Cases:  Government Overreach or Reasonable Oversight +Details
7. Contracting Beyond Traditional Health Care Settings: Model for Virtual First Care (V1C) Payer/Provider Contracts +Details
36. Trends in ERISA Preemption: PBMs, State Consumer Fraud Laws, and State Regulation of Health Care +Details
38. The No Surprises Act and Its Impact on the Future of Managed Care +Details

Physicians and Physician Organizations

20. Show me the Money: How to Advise Physician Practices When Private Equity comes Knocking on Their Door +Details
28. Global and Professional Direct Contracting 201: Redefining Physician Practice to Deliver Value +Details

Professional Development

31. Transitions: Sustaining Attorney Well-Being During Times of Change +Details

Regulation, Accreditation, and Payment

10. Hospital Charges under the Microscope: Operational Implications of the Price Transparency Rule and No Surprises Act +Details
12. Information Blocking: Sharing and Enforcement +Details
17. Telemedicine Post-COVID: Where Are We and What's Next? +Details
22. Provider Co-Location: The Final Word or More to Come? +Details
29. The Public Health Emergency (PHE) is Ending:  What Should Providers Expect Next? +Details
38. The No Surprises Act and Its Impact on the Future of Managed Care +Details

Tax

34. A Tasting of Often Under Appreciated Tax Topics +Details

Teaching Hospitals, Academic Medical Centers, and Research

42. Using Genomic Data in Health Care Research: Legal Considerations to Support Innovation +Details


 

 

[Top of Page]